Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials

portfolio company news
Written By Megan Prock McGrath

Dassault Systèmes today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in life sciences and healthcare through end-to end technology solutions used across the healthcare ecosystem.

Megan Prock McGrath
Previous

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Next

DispatchHealth and Medically Home to Merge, Increasing Access to Hospital-Level Care at Home for Americans